A detailed history of Aqr Capital Management LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Aqr Capital Management LLC holds 18,864 shares of AZN stock, worth $1.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,864
Previous 13,685 37.84%
Holding current value
$1.23 Million
Previous $1.07 Million 37.68%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $397,073 - $453,783
5,179 Added 37.84%
18,864 $1.47 Million
Q2 2024

Aug 14, 2024

BUY
$66.81 - $80.83 $483,771 - $585,290
7,241 Added 112.37%
13,685 $1.07 Million
Q1 2024

May 15, 2024

BUY
$61.03 - $69.57 $81,841 - $93,293
1,341 Added 26.28%
6,444 $436,000
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $22,466 - $25,148
363 Added 7.66%
5,103 $343,000
Q3 2023

Nov 14, 2023

BUY
$64.85 - $71.7 $307,389 - $339,858
4,740 New
4,740 $320,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.